TY - JOUR
T1 - Acute systemic and coronary hemodynamic and serologic responses to cigarette smoking in long-term smokers with atherosclerotic coronary artery disease
AU - Nicod, Pascal
AU - Rehr, Roger
AU - Winniford, Michael D.
AU - Campbell, William B.
AU - Firth, Brian G.
AU - David Hillis, L.
N1 - Funding Information:
From the Departments of Internal Medicine (Cardiovascular Division) and Pharmacology, University of Texas Health Science Center at Dallas, Southwestern Medical School, Dallas, Texas. This study was supported in part by Ischemic SCOR Grants tional Institutes of Health, Bethesda, Maryland; by Research Career Development Award KO 4-HL-00801 (Dr. Campbell) from the National Heart, Lung, and Blood Institute, Bethesda, Maryland and by a grant from the Texas Affiliate of the American Heart Association, Dallas, Texas. Dr. Hillis is an Established Investigator of the American Heart Association, Dallas, Texas. Manuscript received January 3, 1984; revised manuscript received March
PY - 1984
Y1 - 1984
N2 - Previous studies suggested that cigarette smoking 1) inhibits an increase in coronary blood flow that should occur with increased myocardial oxygen demands, and 2) alters thromboxane and prostacyclin production, causing vasoconstriction and platelet aggregation. In 38 smokers (26 men and 12 women, aged 50 ± 8 years [mean ± standard deviation]) with coronary artery disease, systemic and coronary hemodynamic and serologic variables were measured before and after smoking two cigarettes (in 8 to 10 minutes) (21 patients) or 8 to 10 minutes without smoking (17 patients; control group). No variable changed in the control group. Smoking increased (p < 0.05) heart rate-systolic pressure product, cardiac output and maximal first derivative of left ventricular pressure (dP/dt) without significantly changing the coronary sinus concentrations of thromboxane B2 or 6-keto-prostaglandin F1α (the stable metabolites of thromboxane A2 and prostacyclin, respectively). Smoking did not increase coronary flow in 6 of 11 patients with greater than 70% stenosis of the proximal left anterior descending or circumflex coronary artery, or both, whereas it caused an increase in coronary flow in all 10 patients without proximal stenoses (p = 0.006). To determine if smoking altered the response of coronary flow to increased myocardial oxygen demands, 10 smokers (5 men and 5 women, aged 48 ± 9 years) underwent atrial pacing for 5 minutes followed 15 minutes later by atrial pacing for 5 minutes during smoking. In the five patients without proximal left coronary artery stenoses, coronary flow increased 26 ± 29 ml/min with pacing and 45 ± 21 ml/min with pacing/smoking (p = 0.018). In contrast, in the five patients with proximal stenoses, coronary flow increased 39 ± 24 ml/min with pacing, but only 36 ± 16 ml/min with pacing/smoking (p = NS). Thus, in smokers with coronary artery disease, smoking increases myocardial oxygen demands. However, in some individuals with severe proximal stenoses of the left coronary artery, it may induce no change or cause a decrease in coronary blood flow. The net effect of smoking on coronary blood flow appears to be influenced by the location and severity of atherosclerotic coronary artery disease.
AB - Previous studies suggested that cigarette smoking 1) inhibits an increase in coronary blood flow that should occur with increased myocardial oxygen demands, and 2) alters thromboxane and prostacyclin production, causing vasoconstriction and platelet aggregation. In 38 smokers (26 men and 12 women, aged 50 ± 8 years [mean ± standard deviation]) with coronary artery disease, systemic and coronary hemodynamic and serologic variables were measured before and after smoking two cigarettes (in 8 to 10 minutes) (21 patients) or 8 to 10 minutes without smoking (17 patients; control group). No variable changed in the control group. Smoking increased (p < 0.05) heart rate-systolic pressure product, cardiac output and maximal first derivative of left ventricular pressure (dP/dt) without significantly changing the coronary sinus concentrations of thromboxane B2 or 6-keto-prostaglandin F1α (the stable metabolites of thromboxane A2 and prostacyclin, respectively). Smoking did not increase coronary flow in 6 of 11 patients with greater than 70% stenosis of the proximal left anterior descending or circumflex coronary artery, or both, whereas it caused an increase in coronary flow in all 10 patients without proximal stenoses (p = 0.006). To determine if smoking altered the response of coronary flow to increased myocardial oxygen demands, 10 smokers (5 men and 5 women, aged 48 ± 9 years) underwent atrial pacing for 5 minutes followed 15 minutes later by atrial pacing for 5 minutes during smoking. In the five patients without proximal left coronary artery stenoses, coronary flow increased 26 ± 29 ml/min with pacing and 45 ± 21 ml/min with pacing/smoking (p = 0.018). In contrast, in the five patients with proximal stenoses, coronary flow increased 39 ± 24 ml/min with pacing, but only 36 ± 16 ml/min with pacing/smoking (p = NS). Thus, in smokers with coronary artery disease, smoking increases myocardial oxygen demands. However, in some individuals with severe proximal stenoses of the left coronary artery, it may induce no change or cause a decrease in coronary blood flow. The net effect of smoking on coronary blood flow appears to be influenced by the location and severity of atherosclerotic coronary artery disease.
UR - http://www.scopus.com/inward/record.url?scp=0021705814&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021705814&partnerID=8YFLogxK
U2 - 10.1016/S0735-1097(84)80058-3
DO - 10.1016/S0735-1097(84)80058-3
M3 - Article
C2 - 6548482
AN - SCOPUS:0021705814
SN - 0735-1097
VL - 4
SP - 964
EP - 971
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 5
ER -